Obi Greenman
Vermogen: 12 M $ op 30-09-2026
Vermogen: 12 M $ op 30-09-2026
Mr. William M.
Greenman is an Executive Chairman at Cerus Corp.
Mr. Greenman was previously employed as an Independent Director by Aduro BioTech, Inc., an Independent Director by Chinook Therapeutics, Inc., and a Senior Vice President-Biotech Division by Baxter International, Inc. He received his undergraduate degree from Stanford University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERUS CORPORATION 2,51% | 30-06-2026 | 5.053.036 ( 2,51% ) | 12 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CERUS CORPORATION | Voorzitter | 16-03-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-08-2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-01-1995 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau